Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / UNIT 10/04/2029
-
Total 13F shares
-
2,850,577
-
Share change
-
-5,758,056
-
Total reported value
-
$29,710,470
-
Price per share
-
$10.44
-
Number of holders
-
11
-
Value change
-
-$58,558,415
-
Number of buys
-
3
-
Number of sells
-
12
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - UNIT 10/04/2029 (OACCU) as of Q1 2025
As of 31 Mar 2025,
Oaktree Acquisition Corp. III Life Sciences - UNIT 10/04/2029 (OACCU) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,850,577 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, MOORE CAPITAL MANAGEMENT, LP, ADAR1 Capital Management, LLC, Schonfeld Strategic Advisors LLC, Lighthouse Investment Partners, LLC, Affinity Asset Advisors, LLC, WHITEBOX ADVISORS LLC, CITIGROUP INC, Athos Capital Ltd, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.